arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Kyntra Bio, Inc.

KYNB Health Care Biotechnology: Pharmaceutical Preparations
$5.09
▼ -2.3% Today
as of Oct 23, 10:04 ET
Last 30 days -36.61% Sep 14 → Oct 23
$4.60 $5.52 $6.44 $7.36 $8.28 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$5.17
High
$5.34
Low
$5.00
Volume
$9,541
Avg Vol
$25,532
Mkt Cap
$26M
P/E (TTM)
0.10
Beta
—
52w High
$11.39
52w Low
$4.85
Div Yield
—
Shares Out
$4M

Recent Press Releases & News last 60 days · 6 items

▸ Show all 6 press releases & news Free account →

KYNB earnings at a glance

Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±1.6% on average; after the most recent report on May 11, 2026 it moved -2.2%. KYNB beat the consensus EPS estimate in 1 of its last 4 reported quarters. The share price of $5.09 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$4.85
$11
4% of range
Avg surprise (last 4)
-158.8%
Avg reaction (last 2)
-1.6%
0% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-4.25$-2.45$-0.65$1.16$2.96 Actual $-0.81Actual $-0.90Actual $-0.65Actual $-0.33Actual $-3.89Actual $-4.25Actual $-0.16Est $0.03Actual $-3.38Est $-2.25Actual $-1.61Est $-4.01Actual $-3.74Est $-3.36Actual $2.96 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-17M$40M$97M$154M$211M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $2.96 — — — — financials
Mon May 11, 2026Mar/2026 $-3.74 $-3.36 -11.3% -2,238% -2.2% earnings
Mon Nov 10, 2025Sep/2025 $-1.61 $-4.01 +59.9% — — earnings
Mon Aug 11, 2025Jun/2025 $-3.38 $-2.25 -50.2% — — earnings
Mon May 12, 2025Mar/2025 $-0.16 $0.03 -633.3% — -1.0% earnings
Mon Sep 30, 2024Sep 2024 $-4.25 — — — — financials
Sun Jun 30, 2024Jun 2024 $-3.89 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.33 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.65 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.90 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.81 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$-1M$4M—$1M$1M$3M—$123,000
Cost of revenue$2,000$4M—$-58,000$85,000$252,000—$-75,000
Gross profit————————
Operating income$-18M$-14M—$-5M$-12M$-15M—$-48M
Net income$12M$-15M—$201M$-8M$5M—$-17M
EPS (diluted)$2.96$-3.76—$49.61$-1.88$1.15—$-4.25

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$51M$37M$48M$118M$23M$34M$50M$131M
Inventory$3M$3M$4M$4M$4M$3M$3M$24M
Total current assets$97M$101M$99M$133M$162M$149M$197M$245M
Total assets$101M$110M$120M$137M$178M$165M$215M$264M
Long-term debt————————
Total liabilities$109M$119M$115M$120M$359M$340M$398M$466M
Total equity$-30M$-31M$-30M$-17M$-203M$-196M$-226M$-223M

Implied volatility — last 90 days

No IV snapshots yet for KYNB.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

KYNB earnings FAQ

How does KYNB stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.6%, up 0 times and down 2 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.